If you think you may have geographic atrophy (GA), your eye doctor can run tests and do an exam to find out. Here’s what to look for and how to find out if you have it. If you have an advanced stage ...
Type 3 macular neovascularization (MNV) is a unique form of neovascular age-related macular degeneration (AMD) that presents distinct pathogenetic features, clinical manifestations, and prognostic ...
Distinct retinal vessel atrophy patterns may be associated with multiple sclerosis (MS), but further research is needed to assess retinal vessel changes and their underlying role in MS. Changes in the ...
Korea Joongang Daily on MSN
Huons BioPharma wins government backing for advanced macular degeneration eye-drop treatment
Company got backing from the Korea Drug Development Fund for non-invasive peptide-based medication for geographic atrophy, aims to begin Phase 2 trials.
A wireless electronic prosthesis implanted under the retina has been shown to restore central vision in people with an advanced form of dry age-related macular degeneration, leading to improvement in ...
Ocugen, Inc. announced that the Data and Safety Monitoring Board has approved the continuation of the second phase of the Phase 1/2 OCU410 ArMaDa clinical trial for treating geographic atrophy (GA) ...
Please provide your email address to receive an email when new articles are posted on . Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE ...
A recent study published in the journal Npj Parkinson's Disease investigated whether increased thinning rate in the parafoveal ganglion cell-inner plexiform layer (pfGCIPL) and peripapillary retinal ...
Optical coherence tomography (OCT) has emerged as a valuable tool for assessing retinal changes associated with neurodegenerative diseases, including Parkinson’s disease (PD). OCT enables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results